Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-21

FDA Approved: NUEDEXTA — Supplemental Application (Otsuka America Pharmaceutical, Inc)

View source ↗

Summary

FDA approved a supplemental application for NUEDEXTA (dextromethorphan hydrobromide and quinidine sulfate) from Otsuka America Pharmaceutical, Inc., resulting i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NUEDEXTA (DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE)

Snippet

SUPPL AP for NUEDEXTA (DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE)